Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.

Revenue
−0.69%
EPS
+19.3%
Free cash flow
+10.1%

Quarter to September 2026, against a year earlier

72.47 8.97 −11.01%
Market cap
$10.9B
P/E
19.5×
Fwd P/E
18.8×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a
Sep '26 From the 10-Q filed 5 Nov Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
18.09 19.90 19.81 21.94

+8 more quarters

P/S ratio
3.20 3.39 3.76 4.02
P/FCF ratio
13.45 14.50 19.75 20.75
P/Operating CF
37.88 50.88 57.63 47.49
P/B ratio
2.09 2.24 2.46 2.58
EV/Sales
3.28 3.48 3.84 4.12
EV/EBITDA
11.06 11.72 14.27 15.47
EV/FCF
13.81 14.86 20.14 21.28
Current Ratio
4.30 4.62 4.56 4.26
Net Debt/EBITDA
— (2.36) (2.86) (2.27)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
5.53% 5.02% 5.05% 4.56%
Free Cash Flow Yield
7.43% 6.90% 5.06% 4.82%
Free Cash Flow per Share
1.68 1.31 1.20 1.50
Book value per Share
35.75 35.31 34.96 33.82
Free Cash Flow
224.84 176.57 162.75 202.31
EV/EBIT
15.17 17.10 22.31 25.24
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026